Ethics


Decriminalization offers an ethical counterbalance to address sexual misconduct in psychedelic therapy


Sexual violence is already notoriously under-reported, and barriers— including distrust in police—are amplified when victims are also members of a criminalized subculture and were under the influence of illegal drugs when the violence occurred.

MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People


"I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes."

Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved


Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.

Bicycle Day 2020 Was Truly Historic, But Not for the Reasons You Think


Jamon A. Rahn, CEO of psychedelic pharmaceutical startup MindMed, offered a glimpse of the future of psychedelic science, including proprietary data and hints of an “LSD neutralizer.”

How psychedelic clinical trials are being affected by coronavirus


Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.

Amidst Pandemic, Psychedelic Investor Christian Angermayer Can’t Imagine Life Beyond Capitalism


As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer


In response to the coronavirus pandemic, Christian Angermayer—the world's largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.

Dear Psychedelic Researchers


The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge”


“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.

Native American Churches Request that Peyote Not Be Included in Decriminalization Initiatives


A long-fought battle for access to peyote, and a dwindling population in the United States has led Native American Church members and peyote conservationists to request that peyote be left out of decriminalization efforts.

Calm Down. What’s the Worst Thing That the Wellness Industry Could Do to Psychedelics?


As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.

“Making psychedelics boring again”— Unless you’re a privileged psychedelic executive, of course


The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.

Never Forget: Before There Was A Mush Rush, There Was A Plea For Decency


Many predicted an ethical storm brewing in the lead-up to the explosion of for-profit interest in psychedelic pharmaceuticals. But, were their efforts to mitigate the damage enough to make a difference?

Could wearable microdosing technology be a thing one day?


Could a liquid-delivery system meant to help maintain a personalized “scent bubble” quietly usher in the creation of wearable psychedelic microdosing technology? A U.S. patent for this system is just one among an increasing list of psychedelic-inspired intellectual properties.

Lucy In The Sky With Nazis: Psychedelics and the Right Wing


Psychedelic advocates have long asserted that broader psychedelic use will lead to a more open, progressive society, but there are too many instances of right-wingers who have taken them for that to be true.

BBC Duped into Promoting Marketing Scheme for Microdosing Psychedelics


A recent BBC story entitled “The ‘psychedelics coach’ with drug-fuelled career advice,” offers an opportunity to examine what happens when sloppy journalism and self-promotional psychedelic marketers collide.

We Refuse to Endorse Daniel Pinchbeck as a Credible Voice in the Psychedelic Movement


Pinchbeck has not publicly engaged in the difficult work of reorganizing his relationship to power, which is a precondition for learning to wield power and authority responsibly. Instead, he has shown that he is predominantly concerned with reestablishing his career and with recentering himself as an authority figure

As legal psychedelic therapy emerges, ethicists urge for more comprehensive frameworks to address sexual abuse


With a checkered history of misconduct, how will psychedelic-assisted therapists be held accountable in the emerging legal field?

An open letter to the newly founded Center for Psychedelic Research at Johns Hopkins


With the recent creation of the Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine in Baltimore, Maryland, we must remember that, while industrialized medicine has never attempted to serve all people, institutional histories vary from one organization to the next.

Ethics


Decriminalization offers an ethical counterbalance to address sexual misconduct in psychedelic therapy


Sexual violence is already notoriously under-reported, and barriers— including distrust in police—are amplified when victims are also members of a criminalized subculture and were under the influence of illegal drugs when the violence occurred.

MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People


"I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes."

Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved


Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.

Bicycle Day 2020 Was Truly Historic, But Not for the Reasons You Think


Jamon A. Rahn, CEO of psychedelic pharmaceutical startup MindMed, offered a glimpse of the future of psychedelic science, including proprietary data and hints of an “LSD neutralizer.”

How psychedelic clinical trials are being affected by coronavirus


Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.

Amidst Pandemic, Psychedelic Investor Christian Angermayer Can’t Imagine Life Beyond Capitalism


As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer


In response to the coronavirus pandemic, Christian Angermayer—the world's largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.

Dear Psychedelic Researchers


The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge”


“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.

Native American Churches Request that Peyote Not Be Included in Decriminalization Initiatives


A long-fought battle for access to peyote, and a dwindling population in the United States has led Native American Church members and peyote conservationists to request that peyote be left out of decriminalization efforts.

Calm Down. What’s the Worst Thing That the Wellness Industry Could Do to Psychedelics?


As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.

“Making psychedelics boring again”— Unless you’re a privileged psychedelic executive, of course


The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.

Never Forget: Before There Was A Mush Rush, There Was A Plea For Decency


Many predicted an ethical storm brewing in the lead-up to the explosion of for-profit interest in psychedelic pharmaceuticals. But, were their efforts to mitigate the damage enough to make a difference?

Could wearable microdosing technology be a thing one day?


Could a liquid-delivery system meant to help maintain a personalized “scent bubble” quietly usher in the creation of wearable psychedelic microdosing technology? A U.S. patent for this system is just one among an increasing list of psychedelic-inspired intellectual properties.

Lucy In The Sky With Nazis: Psychedelics and the Right Wing


Psychedelic advocates have long asserted that broader psychedelic use will lead to a more open, progressive society, but there are too many instances of right-wingers who have taken them for that to be true.

BBC Duped into Promoting Marketing Scheme for Microdosing Psychedelics


A recent BBC story entitled “The ‘psychedelics coach’ with drug-fuelled career advice,” offers an opportunity to examine what happens when sloppy journalism and self-promotional psychedelic marketers collide.

We Refuse to Endorse Daniel Pinchbeck as a Credible Voice in the Psychedelic Movement


Pinchbeck has not publicly engaged in the difficult work of reorganizing his relationship to power, which is a precondition for learning to wield power and authority responsibly. Instead, he has shown that he is predominantly concerned with reestablishing his career and with recentering himself as an authority figure

As legal psychedelic therapy emerges, ethicists urge for more comprehensive frameworks to address sexual abuse


With a checkered history of misconduct, how will psychedelic-assisted therapists be held accountable in the emerging legal field?

An open letter to the newly founded Center for Psychedelic Research at Johns Hopkins


With the recent creation of the Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine in Baltimore, Maryland, we must remember that, while industrialized medicine has never attempted to serve all people, institutional histories vary from one organization to the next.